Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 18 | 2020 | 202 | 1.860 |
Why?
|
| Pregnancy in Diabetics | 9 | 2020 | 70 | 0.940 |
Why?
|
| Diabetes Mellitus, Type 1 | 10 | 2020 | 529 | 0.890 |
Why?
|
| Pregnancy | 41 | 2020 | 2334 | 0.790 |
Why?
|
| Ultrasonography, Prenatal | 10 | 2010 | 79 | 0.650 |
Why?
|
| Fetal Growth Retardation | 7 | 2007 | 56 | 0.570 |
Why?
|
| Fetal Weight | 5 | 2006 | 33 | 0.430 |
Why?
|
| Acidosis | 3 | 2003 | 31 | 0.410 |
Why?
|
| Birth Weight | 6 | 2007 | 186 | 0.390 |
Why?
|
| Trial of Labor | 2 | 2000 | 5 | 0.370 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2000 | 8 | 0.360 |
Why?
|
| Hemodynamics | 4 | 1999 | 705 | 0.360 |
Why?
|
| Nifedipine | 3 | 1999 | 40 | 0.350 |
Why?
|
| Pregnancy, High-Risk | 2 | 2007 | 14 | 0.350 |
Why?
|
| Pregnancy Trimester, First | 3 | 2020 | 43 | 0.350 |
Why?
|
| Fetal Macrosomia | 2 | 2006 | 7 | 0.330 |
Why?
|
| Dystocia | 1 | 2006 | 4 | 0.280 |
Why?
|
| Shoulder | 1 | 2006 | 37 | 0.280 |
Why?
|
| Anthropometry | 1 | 2006 | 64 | 0.280 |
Why?
|
| Female | 42 | 2020 | 38074 | 0.260 |
Why?
|
| Lipoproteins | 2 | 2019 | 161 | 0.250 |
Why?
|
| Vascular Resistance | 4 | 1999 | 179 | 0.240 |
Why?
|
| Pregnancy Complications | 3 | 2005 | 286 | 0.230 |
Why?
|
| Hypertension | 5 | 2005 | 1535 | 0.220 |
Why?
|
| Labetalol | 2 | 1999 | 10 | 0.220 |
Why?
|
| Chorion | 3 | 2010 | 13 | 0.210 |
Why?
|
| Cardiac Output | 2 | 2000 | 133 | 0.210 |
Why?
|
| Cesarean Section | 5 | 2007 | 101 | 0.210 |
Why?
|
| Gestational Age | 8 | 2006 | 389 | 0.210 |
Why?
|
| Adult | 25 | 2020 | 21403 | 0.210 |
Why?
|
| Calcium Channel Blockers | 2 | 1999 | 138 | 0.210 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1999 | 189 | 0.200 |
Why?
|
| Prospective Studies | 11 | 2017 | 3705 | 0.190 |
Why?
|
| Acoustic Stimulation | 2 | 1999 | 206 | 0.190 |
Why?
|
| Humans | 42 | 2020 | 68618 | 0.190 |
Why?
|
| Oligohydramnios | 3 | 2007 | 7 | 0.190 |
Why?
|
| Obstetric Labor Complications | 1 | 2000 | 20 | 0.180 |
Why?
|
| Predictive Value of Tests | 6 | 2006 | 1465 | 0.180 |
Why?
|
| Labor, Obstetric | 2 | 1999 | 23 | 0.180 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2020 | 58 | 0.180 |
Why?
|
| Twins | 4 | 2010 | 42 | 0.170 |
Why?
|
| Haptoglobins | 1 | 2019 | 12 | 0.170 |
Why?
|
| Fetal Distress | 4 | 2003 | 8 | 0.170 |
Why?
|
| Body Fluids | 1 | 1999 | 41 | 0.170 |
Why?
|
| Tocolytic Agents | 2 | 1997 | 12 | 0.170 |
Why?
|
| Pulmonary Edema | 1 | 1999 | 37 | 0.170 |
Why?
|
| Fetus | 1 | 1999 | 157 | 0.160 |
Why?
|
| Pregnancy Outcome | 4 | 2019 | 157 | 0.160 |
Why?
|
| Electric Impedance | 4 | 2000 | 131 | 0.160 |
Why?
|
| Amnion | 2 | 2010 | 15 | 0.150 |
Why?
|
| Heart Rate | 2 | 1999 | 568 | 0.150 |
Why?
|
| Retrospective Studies | 10 | 2014 | 7277 | 0.150 |
Why?
|
| Vitamin D | 2 | 2020 | 516 | 0.150 |
Why?
|
| Adipokines | 1 | 2017 | 20 | 0.150 |
Why?
|
| Albuminuria | 1 | 2017 | 171 | 0.140 |
Why?
|
| Magnesium Sulfate | 1 | 1995 | 6 | 0.130 |
Why?
|
| Twins, Dizygotic | 1 | 1995 | 25 | 0.130 |
Why?
|
| Infant, Newborn | 10 | 2007 | 2455 | 0.130 |
Why?
|
| Hospitals, Community | 2 | 2014 | 64 | 0.130 |
Why?
|
| Twins, Monozygotic | 1 | 1995 | 27 | 0.130 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 112 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2017 | 307 | 0.120 |
Why?
|
| Zinc | 1 | 2015 | 73 | 0.120 |
Why?
|
| Heart Rate, Fetal | 4 | 2007 | 12 | 0.120 |
Why?
|
| Hospitals, Military | 1 | 2014 | 13 | 0.120 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 58 | 0.110 |
Why?
|
| Stroke Volume | 1 | 1996 | 586 | 0.110 |
Why?
|
| Copper | 1 | 2015 | 149 | 0.110 |
Why?
|
| Hospitals, University | 1 | 2014 | 169 | 0.110 |
Why?
|
| Umbilical Arteries | 2 | 2005 | 9 | 0.110 |
Why?
|
| Placenta, Retained | 1 | 2012 | 1 | 0.100 |
Why?
|
| Pregnancy, Abdominal | 1 | 2012 | 2 | 0.100 |
Why?
|
| Lactation Disorders | 1 | 2012 | 3 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 1996 | 498 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 72 | 0.100 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 1054 | 0.100 |
Why?
|
| Obstetric Labor, Premature | 4 | 2010 | 76 | 0.100 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2003 | 34 | 0.100 |
Why?
|
| Glycation End Products, Advanced | 1 | 2012 | 125 | 0.100 |
Why?
|
| Carotenoids | 1 | 2011 | 45 | 0.100 |
Why?
|
| Biomarkers | 4 | 2020 | 1593 | 0.090 |
Why?
|
| Premature Birth | 2 | 2010 | 150 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 718 | 0.090 |
Why?
|
| Risk | 2 | 2015 | 563 | 0.090 |
Why?
|
| Pregnancy, Multiple | 1 | 2010 | 32 | 0.090 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2010 | 45 | 0.090 |
Why?
|
| Guideline Adherence | 2 | 2003 | 287 | 0.090 |
Why?
|
| Placenta | 2 | 2004 | 101 | 0.090 |
Why?
|
| Emergencies | 3 | 1999 | 107 | 0.090 |
Why?
|
| Blood Pressure | 4 | 2018 | 1451 | 0.080 |
Why?
|
| Risk Factors | 5 | 2019 | 5731 | 0.080 |
Why?
|
| Norway | 2 | 2019 | 18 | 0.080 |
Why?
|
| Young Adult | 4 | 2020 | 5717 | 0.070 |
Why?
|
| Vibration | 2 | 1999 | 32 | 0.070 |
Why?
|
| Infant Mortality | 2 | 2005 | 59 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2006 | 453 | 0.070 |
Why?
|
| Australia | 2 | 2019 | 235 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2012 | 1553 | 0.070 |
Why?
|
| Abdomen | 1 | 2006 | 80 | 0.070 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2006 | 28 | 0.070 |
Why?
|
| Diabetes, Gestational | 1 | 2006 | 81 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2006 | 122 | 0.060 |
Why?
|
| Amniotic Fluid | 2 | 2007 | 30 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2006 | 652 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2019 | 2358 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1046 | 0.050 |
Why?
|
| Cardiotocography | 1 | 2000 | 3 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2003 | 225 | 0.050 |
Why?
|
| Fetal Monitoring | 2 | 2003 | 20 | 0.050 |
Why?
|
| Thorax | 1 | 2000 | 49 | 0.050 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 58 | 0.050 |
Why?
|
| Fetal Blood | 1 | 2000 | 131 | 0.040 |
Why?
|
| Echocardiography | 2 | 2000 | 515 | 0.040 |
Why?
|
| Labor Presentation | 1 | 1999 | 8 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2000 | 249 | 0.040 |
Why?
|
| Body Composition | 1 | 2000 | 119 | 0.040 |
Why?
|
| Administration, Oral | 2 | 1999 | 411 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 1999 | 334 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 1999 | 1738 | 0.040 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2017 | 9 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1999 | 618 | 0.040 |
Why?
|
| Lipocalin-2 | 1 | 2017 | 19 | 0.040 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2017 | 12 | 0.040 |
Why?
|
| Resistin | 1 | 2017 | 9 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2017 | 30 | 0.040 |
Why?
|
| Ductus Arteriosus | 1 | 1997 | 13 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 292 | 0.040 |
Why?
|
| Adiponectin | 1 | 2017 | 52 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 1997 | 81 | 0.040 |
Why?
|
| Leptin | 1 | 2017 | 80 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 2279 | 0.040 |
Why?
|
| Creatinine | 1 | 2017 | 243 | 0.040 |
Why?
|
| Indomethacin | 1 | 1997 | 107 | 0.040 |
Why?
|
| Diphenhydramine | 1 | 1996 | 13 | 0.040 |
Why?
|
| Uterine Contraction | 1 | 1996 | 30 | 0.040 |
Why?
|
| Cardiography, Impedance | 1 | 1996 | 14 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 274 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 947 | 0.030 |
Why?
|
| Zygote | 1 | 1995 | 3 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 772 | 0.030 |
Why?
|
| United States | 2 | 2019 | 7367 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 73 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 122 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 2093 | 0.030 |
Why?
|
| Arkansas | 1 | 2014 | 7 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 867 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 17 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2013 | 21 | 0.030 |
Why?
|
| E-Selectin | 1 | 2013 | 44 | 0.030 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2012 | 19 | 0.030 |
Why?
|
| Lysine | 1 | 2012 | 96 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 180 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 282 | 0.030 |
Why?
|
| South Carolina | 2 | 2014 | 2752 | 0.030 |
Why?
|
| Imidazoles | 1 | 2012 | 175 | 0.020 |
Why?
|
| beta Carotene | 1 | 2011 | 16 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 507 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 1996 | 1851 | 0.020 |
Why?
|
| Perinatal Mortality | 1 | 2010 | 1 | 0.020 |
Why?
|
| Chorionic Villi Sampling | 1 | 2010 | 6 | 0.020 |
Why?
|
| Amniocentesis | 1 | 2010 | 12 | 0.020 |
Why?
|
| Birth Rate | 1 | 2010 | 6 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 521 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 331 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2010 | 42 | 0.020 |
Why?
|
| Vitamin A | 1 | 2011 | 111 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 86 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 1753 | 0.020 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2007 | 46 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 172 | 0.020 |
Why?
|
| Diastole | 1 | 2005 | 161 | 0.020 |
Why?
|
| Adolescent | 1 | 1996 | 8912 | 0.010 |
Why?
|
| Resuscitation | 1 | 2003 | 77 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 2003 | 24 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2223 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 1619 | 0.010 |
Why?
|
| Research Design | 1 | 2005 | 729 | 0.010 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2000 | 11 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2000 | 65 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2005 | 657 | 0.010 |
Why?
|
| Thigh | 1 | 2000 | 27 | 0.010 |
Why?
|
| Medical Records | 1 | 2000 | 121 | 0.010 |
Why?
|
| Arm | 1 | 2000 | 59 | 0.010 |
Why?
|
| Face | 1 | 2000 | 46 | 0.010 |
Why?
|
| Version, Fetal | 1 | 1999 | 8 | 0.010 |
Why?
|
| Breech Presentation | 1 | 1999 | 11 | 0.010 |
Why?
|
| Parity | 1 | 1999 | 71 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 1603 | 0.010 |
Why?
|
| Physical Examination | 1 | 2000 | 152 | 0.010 |
Why?
|
| Asthma | 1 | 2003 | 345 | 0.010 |
Why?
|
| ROC Curve | 1 | 2000 | 392 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2000 | 239 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 1330 | 0.010 |
Why?
|
| Triplets | 1 | 1997 | 9 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 4655 | 0.010 |
Why?
|
| Drug Overdose | 1 | 1996 | 67 | 0.010 |
Why?
|
| Fetal Movement | 1 | 1995 | 4 | 0.010 |
Why?
|
| Sound Spectrography | 1 | 1995 | 14 | 0.010 |
Why?
|
| Sound | 1 | 1995 | 16 | 0.010 |
Why?
|
| Uterus | 1 | 1995 | 77 | 0.010 |
Why?
|
| Oxytocin | 1 | 1996 | 124 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 2077 | 0.010 |
Why?
|
| Male | 1 | 1995 | 37321 | 0.010 |
Why?
|